EQT
51
-3
DD
53
-6
EXPD
43
-4
GILD
47
-8
SWK
50
-5
CL
54
3
AN
50
-5
LMT
30
-2
LUV
45
-2
GE
61
-3
EMR
71
-3
HAS
30
-2
PYPL
52
-2
RIG
43
-7
CINF
53
3
WMT
56
-4
CNX
73
-3
CMI
64
-3
NAVI
52
-2
CMA
61
-3
EQT
51
-3
DD
53
-6
EXPD
43
-4
GILD
47
-8
SWK
50
-5
CL
54
3
AN
50
-5
LMT
30
-2
LUV
45
-2
GE
61
-3
EMR
71
-3
HAS
30
-2
PYPL
52
-2
RIG
43
-7
CINF
53
3
WMT
56
-4
CNX
73
-3
CMI
64
-3
NAVI
52
-2
CMA
61
-3
Financhill
Back

First Trust Dev Mkts Ex-US AlphaDEX® ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
34

FDT
First Trust Dev Mkts Ex-US AlphaDEX® ETF

Last Price:
55.16
Seasonality Move:
3.2%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
34
First Trust Dev Mkts Ex-US AlphaDEX® ETF (FDT) is a Sell

Is First Trust Dev Mkts Ex-US AlphaDEX® ETF a Buy, Sell or Hold?

  • The current First Trust Dev Mkts Ex-US AlphaDEX® ETF [FDT] share price is $56.01. The Score for FDT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • FDT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FDT Stock Price Chart

What is First Trust Dev Mkts Ex-US AlphaDEX® ETF's stock price today?

  • The First Trust Dev Mkts Ex-US AlphaDEX® ETF share price today is $56.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDT is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FDT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 47.24 Sell
Chaikin Money Flow: 165266 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.72 - 56.9) Sell
Bollinger Bands (100): (54.86 - 57.48) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FDT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.14 Sell
20-day SMA: 56.15 Sell
50-day SMA: 56.67 Sell
200-day SMA: 55.63 Buy
8-day EMA: 55.91 Buy
20-day EMA: 56.21 Sell
50-day EMA: 56.38 Sell
200-day EMA: 55.35 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

First Trust Dev Mkts Ex-US AlphaDEX® ETF Earnings Growth & FDT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

First Trust Dev Mkts Ex-US AlphaDEX® ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):